PotentialDid everyone see Amarin Corp shares double today? Two years ago this bio company was at .65. Today after good results from their phase 3 study the shares are trading at $17 for a market cap exceeding $2B. No revenues just a promising drug that lowers triglyceride levels by 21% in clinical studies.
Pharmagap is still a couple of years from this but we have potential. Patience is the key here.
Alan